QPI-1002
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for QPI-1002, covering 2019-01-10 to 2021-07-16. Get the full timeline:
Most recent: Clinical Trial Update: QPI-1002 Phase 3 for Prevention of Major Adverse Kidney Events (MAKE) in Subjects at High Risk for AKI Following Cardiac Surgery [Phase 3]